About
The Emory HPLC Bioanalytical Core team of experts are here to help you achieve your goals. Please reach out with any questions at any stage in the process.
Core Leadership
ELLEN HESS, PHD
Scientific Director
Professor, Pharmacology and Chemical Biology
Dr. Hess received her B.A. in Psychobiology from Wellesley College and Ph.D. in Neuroscience from University of California at San Diego with postdoctoral training at The Scripps Research Institute. Before joining the faculty at Emory University in 2008, she was a Professor at Johns Hopkins University School of Medicine. Dr. Hess’ laboratory works on understanding the pathophysiology of dystonia by understanding the specific dysfunctional neuronal signals. As such, she has expertise in genetics, neurochemistry, pharmacology and behavior. Additionally, Dr. Hess has created and uses many different animal models of dystonia, which her laboratory uses to discover and develop new treatments for dystonia. This work forms the basis of the Antidystonia Drug Discovery Program, which serves as a resource for preclinical antidystonia drug testing for the academic scientific community and the pharmaceutical industry. Dr. Hess has published over 100 scientific papers, chaired numerous scientific review panels, is invited to speak on her work throughout the world and is a thought-leader in her field.
Ellen Hess
HYDER A. JINNAH, MD, PHD
Scientific Director
Professor, Neurology, Human Genetics and Pediatrics
Dr. Jinnah received dual BS degrees in psychology and zoology from Duke University, and M.D. and Ph.D. degrees from the University of California in San Diego. He completed a clinical residency in Neurology at Johns Hopkins. Since 2009, Dr. Jinnah has been Professor of Neurology, Human Genetics and Pediatrics in the Emory School of Medicine. He has more than 20 years’ experience in molecular genetics and biochemistry. He was involved in the early development of HPLC-based protocols to measure monoamine neurotransmitters and their metabolites. These methods have proven to be quite robust and have now been applied to samples from a variety of sources including extracts from brain tissue (e.g. mouse, rat, human, Drosophila) a variety of cultured cell types (e.g. rodent and human neuroblastoma, induced pluripotent stem cells), and other biological fluids (e.g. cerebrospinal fluid, blood, urine). He was also responsible for development of HPLC-based protocols to measure all bioactive purines in a single run. These include adenine nucleotides such as ATP, guanine nucleotides such as GTP, and their many metabolites. He also has experience with development of novel HPLC-based methods for other small organic molecules.
Hyder Jinnah
Core Team
RONG FU, PHD
Core Director
Dr. Fu received her PhD at Georgia State University majored in Biochemistry. She has over 20 years of experience in biochemistry and is highly trained in all areas of the core. She has extensive experience in applying chromatography techniques for small molecular quantitation and qualification, protein purification. She has expertise in HPLC method development and validation for small molecules in the field of biological sciences.
